Citation Select	Birks JS, Harvey RJ Donepezil for dementia due to Alzheimer,s disease Cochrane Database Syst Rev. 2018 06 18;6:CD001190
Citation Select	Nordström P, Religa D, Wimo A, Winblad B, Eriksdotter M The use of cholinesterase inhibitors and the risk of myocardial infarction and death: a nationwide cohort study in subjects with Alzheimer,s disease Eur Heart J. 2013 Sep;34(33):2585-91. doi: 10.1093/eurheartj/eht182. Epub 2013 Jun 4
Citation Select	Mori E, Ikeda M, Kosaka K, on behalf of the Donepezil-DLB Study Investigators on behalf of the Donepezil-DLB Study Investigators, Donepezil for dementia with Lewy bodies: A randomized, placebo-controlled trial. Ann Neurol. 2012 Jul;72(1):41-52
Citation Select	Donepezil "402" Study Group; Seltzer B, Zolnouni P, Nunez M, Goldman R, Kumar D, Ieni J, Richardson S Efficacy of donepezil in early-stage Alzheimer disease: a randomized placebo-controlled trial Arch Neurol. 2004 Dec;61(12):1852-6
Citation Select	McKeith I, Del Ser T, Spano P, Emre M, Wesnes K, Anand R, Cicin-Sain A, Ferrara R, Spiegel R Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study Lancet. 2000 Dec 16;356(9247):2031-6